To construct a simple physiological model of leptin kinetics, based on measures of body size and composition, which is suitable for investigating the influence of genetic and other influences on circulating leptin levels in humans. METHODS: Consideration of the kinetics of the secretion and clearance of leptin led to a predicted linear relationship between ln(leptin), ln(fat mass), and a function of non-fat body compartments. Results obtained from this model were compared with those from two published empirical models based on adjustment for fat mass alone or for body mass index. Overnight fasted leptin levels, body composition data (dual-energy X-ray absorptiometry) and questionnaire responses were obtained from 527 twin pairs (127 monozygotic, 400 dizygotic; 37 male (age 18 -68 y, BMI 18 -32 kg=m 2 ), 489 female (age 18 -71, BMI 17 -44) drawn from the St Thomas' UK Adult Twin Registry. RESULTS: In a partial correlation analysis ln(fat mass) and ln(height) (r ¼ 0.80, P < 0.0001) and r ¼ 70.22, P < 0.0001 respectively) were independent predictors of ln(leptin) in females but ln(lean mass) was not (r ¼ 70.01). A regression model incorporating ln(fat mass), ln(height) and a second order polynomial in age provided an adequate fit of the ln(leptin) data in females (r 2 ¼ 71%). ln(Leptin) values adjusted for body size and composition using the model were not significantly heritable (P ¼ 0.11), were significantly related to gender (r 2 ¼ 2.3%) and to ln(insulin) (r 2 ¼ 5.7%), but not to menopausal status (r 2 ¼ 0.7%), hormone replacement therapy (r 2 ¼ 0.4%), past or current smoking (r 2 ¼ 1.1%), or percentage trunk fat (r 2 ¼ 0.5%). Both empirical models found significant heritability (h 2 ¼ 36 -42%), overestimated the effect of gender in the data (r 2 ¼ 14 -16%), and produced significant relationships between adjusted ln(leptin) and percentage trunk fat (r 2 ¼ 4 -12%). CONCLUSIONS: We conclude that our physiologically based model provides an adequate description of the relationship between leptin and body composition and provides a more reliable framework than current empirical approaches for the investigation of other influences on circulating leptin levels. Heritable variations in the control of leptin secretion are unlikely to contribute significantly to variations in leptin levels at the population level.
Introduction
Circulating leptin concentration is closely related to the level of adiposity, and is almost always elevated in human obesity. However, for any level of adiposity an individual's leptin may fall within a wide concentration range. 1 -4 Independent influences on leptin levels of gender, menopause, smoking, hormonal status, central adiposity and other factors have been reported in cross-sectional studies. 5 In all cases the conclusions reached depend on the adjustment of leptin levels for indices of body composition. How this adjustment is performed may be important in determining the results.
Analysing the between-subject variation in circulating leptin in relation to obesity is a particular problem. The close relationship between the rate of production of leptin and the size of the fat mass potentially confounds the analysis of other influences on leptin. Other influences include distribution into, and clearance from the circulation, both of which would be expected to relate to non-fat body compartment size(s). Others have found relationships between leptin and lean body mass independent of body fat. 6 Relationships with body composition variables account for 70 -80% of the variance in leptin. It seems important to define these relationships as accurately as possible when testing for other effects.
The aim of this study was to develop a simple physiological model of leptin kinetics suitable for an investigation of the influence of factors other than body composition on leptin levels in humans. The results suggest that this approach provides a more reliable framework than those provided by empirical methods.
Methods

Models
Physiological (reference) model I. Circulating leptin concentrations show a diurnal rhythm. 7 Under our conditions of sample collection (overnight fasting) leptin concentrations were approaching the morning nadir, changing at a rate of approximately 8% per hour. 7 We assume that this represents a sufficiently close approximation to a steady state.
The steady-state model ( Figure 1 ) assumes that leptin is secreted at a rate (R a ), which is a function of the mass of adipose tissue (F), into a distribution volume in equilibrium with plasma leptin, and is cleared irreversibly at a rate (R d ) proportional to the amount of leptin in the distribution volume. 8 The effects of leptin binding protein(s) 9 in the distribution space are assumed to be negligible in the steady state and are not included in the model. The contributions of non-fat sources of leptin are assumed to be negligible. To the extent that the secretory mass of these organs covaries with the index of leptin clearance, their contributions would be partially included in the 'clearance' term. This model formalizes the approach taken by Rosenbaum et al to account for the influence of distribution volume and clearance on leptin levels in humans. 10 R a can be represented as a function of the size of the adipose tissue mass (F), while R d can be represented as a function of the leptin present in the distribution volume and the properties of the clearance mechanisms. Thus: The right-hand side of equation (3) contains two elements which are expected to relate to the size of some non-fat components of the body: (i) the distribution volume (V); and (ii) the clearance properties represented in D, which would be expected to scale with the sizes of the clearance organs. Combining these two elements results in:
where f 3 is an unspecified function and X represents the influence of non-fat components of the body on leptin distribution and clearance. The processes represented by functions f 1 and f 3 are known to be complex and include effects of the neuroendocrine system on leptin secretion, effects of circulating binding proteins and the amount, properties and tissue distribution of leptin receptors. For the purposes of our analysis we chose to represent them in terms of products of power functions of the measured variables, which satisfy the boundary conditions as the variables tend to zero, and can accommodate some monotonic curvature in the underlying relationships. Curvature would be expected particularly in leptin clearance which appears to saturate at high physiological levels.
11 Thus:
rearrangement and ln-transformation gives
Where
Equation (6) is in a form suitable for linear regression analysis where X is one of the two candidate predictors of the size of the relevant lean body compartment (height and lean body mass). For the regression analyses described below a yintercept term (b 0 ) was included; the value of this intercept is dependent on the scales of measurement of the dependent and independent variables. Further adjustments to model predictions were based on relationships with age. Ideally, influences of age on the separate components of the model (leptin production and clearance) would be tested. However in preliminary analyses using non-linear regression models it was not possible to obtain reliable estimates of potentially separate effects of age on the two processes and so an 
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Empirical models II and III. The physiological model described above (model I) was compared with published empirical models based on fat mass (model II,
).
Subjects
Subjects were drawn from series of predominantly female twin volunteers recruited by the St Thomas' UK adult twin registry based in London. 13 The phenotypic data is part of a proprietary database (PHENOBASE TM ) owned by Gemini Genomics Plc, Cambridge, UK. All volunteers gave written informed consent for the anonymous use of the data and the study was approved by the St Thomas' Hospital Research Ethics Committee. Because of the statistical problems posed by relatedness of measurements within twin pairs, the sample for most of the present study consisted of only one member of each twin pair (the individuals arbitrarily designated twin no. 1 in the database). Twin pairs for whom body composition and plasma leptin data from both twins were available for analysis on 2 February 1999, with verified fasting status at the time of blood collection, without history of diabetes, and with a fasting blood glucose < 7.0 mmol=l, were included in the analyses.
Body composition and plasma hormone measurements
Whole body dual energy X-ray absorptiometry (DXA, Hologic QDR-2000, Waltham, MA, USA) was used to measure body composition (total fat mass, trunk fat mass and lean body mass). Trunk fat was calculated from the regions chest, abdomen and pelvis using standard landmarks. Plasma leptin and insulin concentrations were determined after an overnight fast using commercial radioimmunoassays (leptin, Linco Research, St Louis, MO; Insulin, Immunodiagnostics Enzum test, Boehringer Mannheim). Fasting status was assessed by questionnaire (time of last food) and only subjects who had not eaten for at least 6 h were included in this study. Leptin and all total body composition and height data were available for all male and female subjects. Trunk fat and insulin data were available for a subset of the females (n ¼ 348).
Menopausal, hormone replacement therapy and smoking status Menopausal status (amenorrhea > 12 months) and duration were determined by standardized questionnaires administered by trained staff, as was smoking habit (current, past and duration of use) and hormone replacement therapy (current, past).
Statistical methods
All analyses, except heritability, used only one member (no. 1) of each twin pair. Leptin, fat and lean body mass, and height data were analysed after natural logarithm (ln) transformation as a consequence of the form of the model. The resulting distributions were approximately normal with no significant skewness. Marked skewness in the insulin data was corrected by ln transformation. Partial correlations among ln(leptin), ln(total fat mass), ln(lean body mass) and ln(height) were used to identify the best predictor of non-fat related variance in leptin levels in female subjects only. The parameters of a multiple linear regression relationship between ln(leptin) and the chosen body composition variables were used to adjust all individuals' ln(leptin) values to the female population means of the predictor variables. The relationship between adjusted ln(leptin) levels in females and age was examined by polynomial regression of adjusted ln(leptin) against powers (1 -3) of age. On the basis of these results a second-order polynomial expression in age was incorporated into the multiple regression model and the resulting regression parameters were used to adjust all individuals' ln(leptin) values to the female population means of ln(total fat mass), ln(height) and age. Relationships between these adjusted ln(leptin) values and gender, menopausal status, HRT status and smoking status were analysed by one-way analysis of variance. The effect of gender was also examined (i) in a subset of males and females (n ¼ 33 of each) individually matched with respect to predicted ln(leptin) levels derived from the above model (ie matched for the combined effects of the covariates in the model), and (ii) by incorporating into the above model gender and its interactions with ln(fat mass) and ln(height) in an analysis of the whole twin no 1 data set. With main effects containing more than two levels, Dunnett's test was used for post hoc comparisons of 'treatment' groups with a designated control group. Relationships between continuous variables were assessed by linear regression analysis. To further investigate relationships between leptin and regional fat distribution the reference model (model la) was modified to include separate relationships between ln(leptin) and central (trunk) and peripheral (total7trunk) fat; the resulting model was fitted using non-linear regression. Normality of distributions was tested using the Shapiro-Wilks W-test. Mahalanobis distances were used to identify multivariate outliers using the criterion P < 0.001. Estimates and 95% confidence intervals for additive genetic (h 2 , heritability) and common (c 2 ) and specific (e 2 ) environmental influences on the various phenotypes were obtained by univariate modelling of variance-covariance matrices in female monozygotic (MZ) and dizygotic (DZ) twin pairs 14 using Mx software. 11 Results are presented for the best-fitting and most parsimonious models based on the residual w 2 .
In addition, heritabilities were tested against zero using a Wilcoxon two-group test of the effect of zygosity on absolute within-pair phenotypic differences. All analyses other than the variance-covariance modeling were performed using JMP software (V 3.1.6.2, SAS 
Results
Subject characteristics
Characteristics of the 527 subjects are shown in Table 1 . Ages ranged from 18 to 71 y in females and 18 -68 y in males. There was a wide range of body mass index in both females (17 -44 kg=m 2 ) and males (18 -32 kg=m 2 ). Unequivocal menopausal status was available in 289 females of whom 73 were post-menopausal. Of the post-menopausal women 18 were currently receiving and 14 had previously received HRT. Smoking status was available for 439 female subjects (239 never, 96 ex and 104 current smokers).
Correlation analyses
In simple correlations ln(leptin) had significant relationships with ln(fat mass), ln(lean body mass) and ln(height) (r ¼ 0.83, 0.25 and 70.12, respectively, all P < 0.01). In a partial correlation analysis both ln(fat mass) and ln(height) were significantly related to ln(leptin) (r ¼ 0.80 and 70.22, respectively, both P < 0.001), but there was no relationship with ln(lean body mass) (r ¼ 70.01). On the basis of these results, height was selected as a suitable index in these data of the non-fat compartment(s) determining the distribution and clearance of leptin in the model (X in equation (4)).
Regression analyses
The parameters of the model were estimated using data from female subjects by multiple linear regression analysis of ln(leptin) against ln(fat mass) and ln(height) ( Table 2 , model Ia). The regression model provided a good fit, judged by the proportion of variance explained (69%), normality of residuals (W ¼ 0.99, P ¼ 0.98), and the low occurrence of multivariate outliers. Only two potential multivariate outliers were identified and exclusion of both from the analysis had minimal effects on the fit of the model and on the parameter estimates. Adjusted ln(leptin) levels in Determinants of circulating leptin AB Jenkins et al females calculated using these model parameters were significantly related to age; a stepwise polynomial regression identified significant linear and squared terms in age. Consequently the multiple regression model was expanded to include this relationship. The resulting model parameters (Table 2 , model Ib) were used to calculate the predicted ( Figure 2 ) and adjusted ln(leptin) values used in subsequent analyses.
Gender, menopause and HRT Adjusted leptin. Gender had a highly significant effect on the adjusted ln(leptin) values (P ¼ 0.0004), equivalent to a 20% lower leptin level in male subjects after adjustment for the ln(fat), ln(height) and age ( Figure 3A) . Similar results were obtained in a subset of males and females matched with respect to predicted ln(leptin) levels derived from the model; predicted ln(leptin) levels were not different between males (1.94 AE 0.09) and females (1.95 AE 0.09), but there was a highly significant effect of gender on adjusted ln(leptin) ( Figure 3A ). The effects of including gender and its interactions with ln(fat mass) and ln(Ht) in the model are shown in Table 2 (model Ic). The only significantly effect containing gender was the interaction term with ln(fat mass); other effects in the model were substantially unchanged except that the slope of the relationship with ln(fat mass), which represents the average of the slopes in males and females, was not different to 1. Within the female subjects, neither menopausal status ( Figure 3B , P ¼ 0.14) nor HRT ( Figure 3C , P ¼ 0.87) had significantly effects on adjusted ln(leptin) levels. Menopausal status is confounded by age and an effect of the menopause could therefore be obscured by the age adjustment in the model. However age was preferred over menopausal status in a stepwise regression (not shown). It appears from Figure 2A that a small number of the male subjects were not well accommodated by the model. However, when the model predictions are plotted against measured leptin on the original scale ( Figure 2B ), these Table 3 for statistical analysis.
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Smoking
Smoking status had no significant effect on adjusted ln(leptin) levels (P ¼ 0.09, Figure 2D) . Although there appears to be a tendency for ex-smokers to have higher and current smokers lower adjusted ln(leptin), neither group was significantly different to non-smokers (P > 0.05, Dunnett's test).
Abdominal fat and insulin
Adjusted ln(leptin) did not relate significantly to truncal adiposity (Table 3) ; when potentially separate relationships between ln(leptin) and trunk and peripheral fat were incorporated into model 1a and fitted using non-linear regression, similar exponents were found for each fat region (trunk fat 1.47 AE 0.05, peripheral fat 1.18 AE 0.11). ln(Insulin) accounted for 5.7% of the variance in adjusted ln(leptin) (P < 0.0001, Table 3 ). Table 3 compares the reference model with adjusted lntransformed leptin and with two representative empirical models used to adjust leptin for the influences of body composition. The two empirical models accounted for similar proportions of the variance in the dependent variable (leptin vs BMI, r 2 ¼ 0.62; ln(leptin) vs fat mass, r 2 ¼ 0.61). Both empirical models substantially overestimated the effect of gender on adjusted leptin levels compared to the reference model, irrespectively of age adjustments (14 -16% vs 2.3% of the variance). All models lead to similar negative conclusions regarding the influences of menopausal status, HRT and smoking. However, significant relationships with a measure of central adiposity (percentage trunk fat) was seen in both empirical models, but not in the reference model. Relationships with ln(insulin) accounted for similar portions of the variance (6 -11%) with all methods of adjustment (Table 3) .
Empirical models
Heritability
Plasma leptin was strongly heritable whether analysed untransformed (h 2 ¼ 0.6, 95% CI 0.50 -0.69, P < 0.0001) or after ln-transformation (0.65, 0.55 -0.73, P < 0.0001) as were to a lesser extent the two empirically adjusted measures (model II 0.36, 0.23 -0.47; P ¼ 0.03; model III 0.42, 0.30 -0.53, P ¼ 0.002). However, the measure derived from the reference model (model I) showed no significant heritability (P ¼ 0.11) and the variance -covariance structure was best fitted by a model incorporating only common (c 2 ¼ 0.20, 0.12 -0.29) and specific (e 2 ¼ 0.80, 0.71 -0.89) environmental effects.
Discussion
A simple model based on physiological principles provides an adequate description of the relationship between circulating leptin concentrations and measures of body size and composition in a sample of females. The proportion of variance accounted for by body size and composition and age (71%) was similar to that found in other studies using empirical approaches. The unexplained variance (29%) represents the influence of factors outside the model including measurement error as well as biological influences. Within subject variations and measurement errors in leptin accounted for 13% of the variance in ln(leptin) in a group of 17 women studied twice under identical conditions after a 4 week interval (M Gordon, A Jenkins, unpublished observations). Since this design controls for within subject variations in menstrual cycle phase, the within-subject and measurement error contribution to the variance in the present study is likely to be higher. This, together with any 
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AB Jenkins et al contribution from errors in the independent variables, suggests that no more than 16% of the variance in ln(leptin) in the present study is related to biological factors outside the model. ln(Insulin) accounted for 5.7% of the variance in ln(leptin) after adjustment for the covariates in the model. Other influences would include variations in renal functions or other aspects of the clearance mechanisms. The estimate of the exponent relating height to leptin level (Table 2) are consistent with the assumption that height is an index of body compartment size. Compartment or organ size is expected to scale with the cube of a linear dimension such as height, not significantly different from any of the estimates in Table 2 (models Ia, Ib and Ic). This estimated exponent (b 2 , equation, (6)) represents two underlying processes in the model (a 1 and a 3 , equation 5) . However, it is likely that the exponent describing the influence of leptin on its own clearance rate (a 3 ) is close to 1 over most of the range of leptin concentrations (ie approximately first order kinetics) and < 1 at high leptin levels due to saturation of clearance mechanisms. 15 Following similar reasoning, the magnitude of the exponent describing the relationship between fat mass and leptin level (b 1 , equation (6)) in females (1.45 AE 0.04, Table 2 , model Ia) is inconsistent with the simplest expectation of a linear relationship between fat mass and leptin secretion rate (a 1 ), being significantly > 1 (P < 0.0001). This result implies that as fat mass increases leptin secretion increase disproportionately. 8, 11, 16 However, when gender was included in the model, the resulting estimate of the exponent relating ln(leptin) and ln(fat mass) was no longer different from 1 (1.10 AE 0.06, Table 2 , model Ic). This represents the average relationship in males and females, and suggests that the gender effect, whatever its mechanisms, acts to vary leptin secretion either side of close proportionality with total fat mass.
Evidence from both animals and humans points to the kidney as the major site of leptin clearance. 8, 11 Height has been shown to be a strong predictor of renal plasma flow in adults across a range of body compositions. 17 It is therefore not surprising that height is a better index of the distribution and clearance components of the kinetic model than is lean body mass. The major determinant of lean body mass is skeletal muscle mass and this is subject to sources of interindividual variation, such as activity levels, which may not relate to the size of the clearance organs.
The effect of gender on adjusted leptin was weaker in the reference model than in the empirical models, but still substantial, equivalent to a 25% increase in females. A lower proportion of visceral fat in females, which has lower leptin secretion than subcutaneous fat, 18 has been suggested to contribute. No support for this was found in the present study in that (i) there was no relationship between truncal adiposity and ln(leptin) after adjustment with the reference model, and (ii) fitting separate relationships between ln(leptin) and trunk and peripheral fat resulted in a similar but higher exponent for truck fat (1.47 AE 0.05) compared to that for peripheral fat (1.18 AE 0.11). Effects of sex steroids on leptin expression or secretion have been reported, 19, 20 with an inhibitory effect of testosterone appearing stronger and more reproducible than stimulatory effects of oestrogens. In the present study there were no effects of menopausal status or HRT on adjusted leptin levels irrespective of the method of adjustment for body composition. This suggests that stimulatory effects of females oestrogens may be less important than suppressive effects of male androgens to the gender difference in leptin transcription and secretion.
It appeared that some male subjects with low levels of body fat were not well accommodated by the model (Figure  2A ). Whether this reflects a gender-specific effect or an effect due to low levels of body fat irrespective of gender cannot be determined from these data due to the lack of comparable female subjects. In any case, the deviations from the model are less striking when looked at on the original scale ( Figure  2B ). It may be that at such low body fat content (7%) other sources of leptin become the major determinants of variations in circulating leptin levels.
The method of adjustment for body composition had a substantial effect on the estimate of heritability of leptin. Unadjusted serum leptin concentration was strongly heritable as found in previous studies. 21 However the extent to which this heritability is independent of body fatness (which is itself strongly heritable), and hence possibly derived from heritable variations in the leptin secretory function of fat, has been unclear. While both empirical models resulted in significant heritability in the adjusted leptin measures, the reference model did not. While there can be no definitive grounds within this study for choosing between the conflicting results of the different approaches, it is most likely that the empirical models fail to correct adequately for strong heritabilities in body compartment sizes. The present results therefore suggest that heritable variations in the mechanisms controlling leptin secretion are unlikely to contribute substantially to variations in circulating leptin at the populations level. The results of the variance-covariance modelling suggested a significant contribution of common environment influences (c 2 ¼ 20%). It must be noted, however, that distinguishing between dominant genetic and common environmental influences is difficult using this approach, and there remains therefore the possibility that dominant genetic influences play a small role in determining the relationship between body fat and leptin level in this population.
The present results have general implications for the understanding of the roles of physiological and other factors in accounting for inter-individual variations in leptin levels. Unless steps are taken to choose an appropriate form of relationship between measures of adiposity and serum leptin, and to adjust for body size-related differences in leptin clearance, using height or other appropriate measures, other sources of variation may be obscured or spuriously identified. This is likely to be particularly important in genetic studies since both adiposity and height (and presumably distribution volume and clearance organ size) are Determinants of circulating leptin AB Jenkins et al strongly heritable, and this will contaminate estimates of heritability of and genetic linkage to variations in circulating leptin concentration. Similar considerations will apply to other endocrine products of adipose tissue.
